A carregar...
Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control
Type 2 diabetes mellitus (T2DM) is a family of metabolic disorders characterized by hyperglycemia as a consequence of abnormalities in insulin secretion and insulin sensitivity. It affects hundreds of millions of people worldwide and leads to increased morbidity, compromised quality of life, higher...
Na minha lista:
| Publicado no: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446679/ https://ncbi.nlm.nih.gov/pubmed/31016169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_160_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|